Back

Aberrant Immune Programming In Neutrophils In Cystic Fibrosis

Hu, Y.; Bojanowski, C. M.; Britto, C. J.; Wellems, D.; Song, K.; Scull, C.; Jennings, S.; Li, J.; Kolls, J. K.; Wang, G.

2023-01-25 allergy and immunology
10.1101/2023.01.22.23284619
Show abstract

Cystic fibrosis (CF) is a life-shortening genetic disorder, caused by mutations in the gene that encodes Cystic Fibrosis Transmembrane-conductance Regulator (CFTR), a cAMP-activated chloride and bicarbonate channel. Although multiple organ systems can be affected, CF lung disease claims the most morbidity and mortality due to chronic bacterial infection, persistent neutrophilic inflammation, and mucopurulent airway obstruction. Despite the clear predominance of neutrophils in these pathologies, how CFTR loss-of-function affects these cells per se remains incompletely understood. Here, we report the profiling and comparing of transcriptional signatures of peripheral blood neutrophils from CF participants and healthy human controls (HC) at the single-cell level. Circulating CF neutrophils had an aberrant basal state with significantly higher scores for activation, chemotaxis, immune signaling, and pattern recognition, suggesting that CF neutrophils in blood are prematurely primed. Such an abnormal basal state was also observed in neutrophils derived from an F508del-CF HL-60 cell line, indicating an innate characteristic of the phenotype. LPS stimulation drastically shifted the transcriptional landscape of HC circulating neutrophils towards a robust immune response, however, CF neutrophils were immune-exhausted. Moreover, CF blood neutrophils differed significantly from CF sputum neutrophils in gene programming with respect to neutrophil activation and aging, as well as inflammatory signaling, highlighting additional environmental influences on the neutrophils in CF lungs. Taken together, loss of CFTR function has intrinsic effects on neutrophil immune programming that leads to premature priming and dysregulated response to challenge.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Cystic Fibrosis
based on 10 papers
Top 0.1%
12.9%
2
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
11.3%
3
Nature Immunology
based on 14 papers
Top 0.1%
5.4%
4
Cell Genomics
based on 34 papers
Top 0.2%
5.4%
5
Nature Communications
based on 483 papers
Top 15%
5.1%
6
Allergy
based on 13 papers
Top 0.4%
4.8%
7
European Respiratory Journal
based on 44 papers
Top 1%
4.6%
8
Clinical Immunology
based on 12 papers
Top 0.3%
3.0%
50% of probability mass above
9
The Journal of Immunology
based on 19 papers
Top 0.5%
2.9%
10
PLOS ONE
based on 1737 papers
Top 79%
2.9%
11
eLife
based on 262 papers
Top 10%
2.6%
12
Cell Reports Medicine
based on 49 papers
Top 2%
2.5%
13
JCI Insight
based on 63 papers
Top 3%
2.5%
14
Scientific Reports
based on 701 papers
Top 65%
2.3%
15
Frontiers in Immunology
based on 140 papers
Top 4%
1.8%
16
Science Immunology
based on 15 papers
Top 0.6%
1.6%
17
Journal of Clinical Investigation
based on 50 papers
Top 2%
1.6%
18
Communications Biology
based on 36 papers
Top 2%
1.3%
19
EBioMedicine
based on 21 papers
Top 0.5%
1.3%
20
Immunity
based on 11 papers
Top 0.7%
1.3%
21
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 1%
1.3%
22
Cell
based on 28 papers
Top 2%
1.2%
23
Journal of Clinical Immunology
based on 11 papers
Top 0.6%
0.8%
24
The American Journal of Human Genetics
based on 77 papers
Top 6%
0.8%
25
Clinical Epigenetics
based on 21 papers
Top 2%
0.8%
26
eBioMedicine
based on 82 papers
Top 8%
0.7%